These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28866371)

  • 1. No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer.
    De La Pena H; Sharma A; Glicksman C; Joseph J; Subesinghe M; Traill Z; Verrill C; Sullivan M; Redgwell J; Bataillard E; Pintus E; Dallas N; Gogbashian A; Tuthill M; Protheroe A; Hall M
    Eur J Cancer; 2017 Oct; 84():354-359. PubMed ID: 28866371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
    Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
    Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine chest X-rays have no additional value in the detection of relapse during routine follow-up of patients treated with chemotherapy for disseminated non-seminomatous testicular cancer.
    Gietema JA; Meinardi MT; Sleijfer DT; Hoekstra HJ; van der Graaf WT
    Ann Oncol; 2002 Oct; 13(10):1616-20. PubMed ID: 12377651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours.
    Chung P; O'Malley ME; Jewett MAS; Bedard PL; Panzarella T; Sturgeon J; Moore MJ; Hamilton R; Hansen AR; Anson-Cartwright L; Gospodarowicz M; Warde P
    Eur Urol Oncol; 2019 Jul; 2(4):437-442. PubMed ID: 31277780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours.
    Lassen U; Daugaard G; Eigtved A; Højgaard L; Damgaard K; Rørth M
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):396-402. PubMed ID: 12634968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
    Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer--a necessary risk?
    Harvey ML; Geldart TR; Duell R; Mead GM; Tung K
    Ann Oncol; 2002 Feb; 13(2):237-42. PubMed ID: 11886000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
    Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
    J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
    Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance.
    Thompson PI; Nixon J; Harvey VJ
    J Clin Oncol; 1988 Oct; 6(10):1597-603. PubMed ID: 2459319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are lymphangiograms necessary before placing patients with nonseminomatous testicular tumors on surveillance?
    Wishnow KI; Johnson DE; Tenney D
    J Urol; 1989 May; 141(5):1133-5. PubMed ID: 2540349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
    Pizzocaro G; Zanoni F; Salvioni R; Milani A; Piva L; Pilotti S
    J Urol; 1987 Dec; 138(6):1393-6. PubMed ID: 2824862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and staging of germ-cell tumours of the testis].
    Mottet N; Berger N; Droz JP
    Rev Prat; 2007 Feb; 57(4):365-78. PubMed ID: 17455738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.
    Howard SA; Gray KP; O'Donnell EK; Fennessy FM; Beard CJ; Sweeney CJ
    AJR Am J Roentgenol; 2014 Oct; 203(4):W415-20. PubMed ID: 25247970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer.
    Studer UE; Fey MF; Calderoni A; Kraft R; Mazzucchelli L; Sonntag RW
    Eur Urol; 1993; 23(4):444-9. PubMed ID: 7687549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer.
    Escudero-Ávila R; Rodríguez-Castaño JD; Osman I; Fernandez F; Medina R; Vargas B; Japón-Rodríguez M; Sancho P; Perez-Valderrama B; Praena-Fernández JM; Duran I
    Clin Transl Oncol; 2019 Jun; 21(6):796-804. PubMed ID: 30470992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidentally detected testicular lesions <10 mm in diameter: can orchidectomy be avoided?
    Scandura G; Verrill C; Protheroe A; Joseph J; Ansell W; Sahdev A; Shamash J; Berney DM
    BJU Int; 2018 Apr; 121(4):575-582. PubMed ID: 29032579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.